Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Restructuring Costs: 2020-2024

Historic Restructuring Costs for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $50.9 million.

  • Cellebrite DI's Restructuring Costs rose 46.06% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year increase of 24.81%. This contributed to the annual value of $50.9 million for FY2024, which is 17.17% up from last year.
  • As of FY2024, Cellebrite DI's Restructuring Costs stood at $50.9 million, which was up 17.17% from $43.4 million recorded in FY2023.
  • Cellebrite DI's 5-year Restructuring Costs high stood at $50.9 million for FY2024, and its period low was $32.1 million during FY2020.
  • Its 3-year average for Restructuring Costs is $45.1 million, with a median of $43.4 million in 2023.
  • Its Restructuring Costs has fluctuated over the past 5 years, first skyrocketed by 49.18% in 2021, then fell by 14.78% in 2022.
  • Cellebrite DI's Restructuring Costs (Yearly) stood at $32.1 million in 2020, then soared by 49.18% to $47.9 million in 2021, then decreased by 14.78% to $40.9 million in 2022, then rose by 6.34% to $43.4 million in 2023, then rose by 17.17% to $50.9 million in 2024.